US20010009958A1 - Process for preparing aryl-iminomethyl-carbamino acid esters - Google Patents

Process for preparing aryl-iminomethyl-carbamino acid esters Download PDF

Info

Publication number
US20010009958A1
US20010009958A1 US09/757,253 US75725301A US2001009958A1 US 20010009958 A1 US20010009958 A1 US 20010009958A1 US 75725301 A US75725301 A US 75725301A US 2001009958 A1 US2001009958 A1 US 2001009958A1
Authority
US
United States
Prior art keywords
formula
compound
denotes
phenyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/757,253
Other versions
US6417382B2 (en
Inventor
Joerg Brandenburg
Rolf Schmid
Rainer Soyka
Ralf Anderskewitz
Rolf Bauer
Rainer Hamm
Jutta Kroeber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10000907A external-priority patent/DE10000907A1/en
Application filed by Individual filed Critical Individual
Priority to US09/757,253 priority Critical patent/US6417382B2/en
Assigned to BOEHRINGER INGELHEIM PHARMA KG reassignment BOEHRINGER INGELHEIM PHARMA KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHMID, ROLF, SOYKA, RAINER, ANDERSKEWITZ, RALF, BRANDENBURG, JOERG, BAUER, ROLF, HAMM, RAINER, KROEBER, JUTTA
Publication of US20010009958A1 publication Critical patent/US20010009958A1/en
Priority to US10/138,955 priority patent/US6861547B2/en
Application granted granted Critical
Publication of US6417382B2 publication Critical patent/US6417382B2/en
Assigned to BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG reassignment BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: BOEHRINGER INGELHEIM PHARMA KG
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Definitions

  • the invention relates to a process for the production of compounds of general formula (I)
  • the problem of the present invention is to provide a process which can be used for industrial-scale synthesis of compounds of general formula(I) in high yields and with end products of high purity.
  • the invention provides a process for preparing compounds of general formula (I)
  • R 1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me 2 )phenyl, each of which may be mono-, di- or trisubstituted by hydroxy;
  • R 2 denotes a group selected from among methyl, ethyl, propyl and benzyl, characterised in that a compound of general formula (II)
  • R 1 ′ denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me 2 )phenyl, each of which may be mono-, di- or trisubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and is then treated with a compound of formula (III)
  • R 2 is as hereinbefore defined and
  • X′ denotes chlorine, bromine or —O—R 2 , after working up using an acid of formula HY a compound of formula (IV)
  • the compounds of formulae (I) and (IV) also include the corresponding tautomers of formulae (I-T) and (IV-T):
  • alkali metal hexaalkyldisilazane as used above and hereinafter to denote the reagent which is reacted with the compound of formula (II) generally designates a compound of formula (VIII)
  • Met denotes an alkali metal, preferably lithium, sodium or potassium, particularly lithium, and
  • R 3 independently in each case denotes a C 1-4 -alkyl group, preferably methyl or ethyl, especially methyl.
  • lithium hexamethyldisilazane sodium hexamethyldisilazane and potassium hexamethyldisilazane, particularly lithium hexamethyldisilazane.
  • the term “subsequent reaction” with a compound of formula (III) covers both procedures in which the product of the reaction of the compound of formula (II) with the alkali metal hexamethyldisilazane is reacted with the compound of formula (III) directly, without any further intermediate reaction, and also procedures in which the free amidine base is liberated in the mean time from the product formed.
  • the product of the reaction of the compound of formula (II) with the alkali metal hexamethyldisilazane is reacted with the compound of formula (III) directly, especially in a “one-pot synthesis”.
  • a preferred process for preparing compounds of general formula (I) is one wherein
  • R 1 denotes a group selected from among phenyl, benzyl and —C(Me 2 )phenyl, each of which may be mono- or disubstituted, preferably monosubstituted by hydroxy;
  • R 2 denotes a group selected from among ethyl, propyl and benzyl, characterised in that a compound of general formula (II)
  • R 1 ′ denotes a group selected from among phenyl, benzyl and —C(Me 2 )phenyl, each of which may be mono- or disubstituted, preferably monosubstituted by a group —O —PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, preferably 2-tetrahydropyranyloxy,
  • R 2 is as hereinbefore defined and
  • X′ denotes chlorine, bromine or —O—R 2 ,
  • R 1 denotes —C(Me 2 )phenyl which may optionally be monosubstituted by hydroxy and
  • R 2 denotes ethyl
  • R 1 ′ denotes —C(Me 2 )phenyl, which may optionally be monosubstituted by a group —O —PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, preferably 2-tetrahydropyranyloxy,
  • R 2 is as hereinbefore defined and
  • X′ denotes chlorine, bromine or —O—R 2 , preferably chlorine, after working up with aqueous hydrochloric acid a compound of formula (IVA) wherein the groups R 1 and R 2 are as hereinbefore defined is isolated and from this the compound of formula (I) is liberated.
  • the compound of formula (II) is prepared in a process comprising the following steps:
  • R′ denotes C 1-4 -alkyl
  • R 1 ′ denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me 2 )phenyl, each of which is optionally mono-, di- or trisubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy,; optionally in the form of the corresponding sodium or potassium phenoxides, under basic reaction conditions, preferably in a polar organic solvent.
  • hydrochlorides of formula (IVA) are of central importance in the process according to the invention for preparing the compounds of general formula (I). They are obtained directly in high yields as readily crystallising salts, from which by-products and/or impurities can easily be removed by crystallisation. Accordingly, one aspect of the present invention relates to intermediate products of general formula (IVA)
  • R 1 ′ may be as hereinbefore defined are obtained according to the invention by reacting a compound of formula (V)
  • R 1 ′ may be as hereinbefore defined and wherein the compound of formula (VI) may optionally also be used in the form of the sodium and potassium phenoxides thereof, under basic reaction conditions in a polar organic solvent.
  • R 1 may be as hereinbefore defined by reacting a compound of formula (V) wherein X denotes hydroxy, chlorine or mesylate, more preferably hydroxy or chlorine, most preferably chlorine, with a compound of formula (VI) wherein R 1 ′ may be as hereinbefore defined and wherein the compound of formula (VI) is used in the form of the alkali metal phenoxides thereof, preferably in the form of the sodium phenoxides thereof.
  • X may be as hereinbefore defined and most preferably may denote hydroxy or chlorine.
  • R′ denotes C 1-4 -alkyl, preferably methyl or ethyl, most preferably methyl.
  • a compound of general formula (II) is slowly metered into a solution of the alkali metal hexaalkyldisilazane, preferably lithium bis(trimethylsilyl)-amide, sodium bis(trimethylsilyl)-amide, most preferably lithium bis(trimethylsilyl)-amide, in an ethereal or aromatic organic solvent, preferably in a solvent selected from among tetrahydrofaran, toluene, dioxane, more preferably in tetrahydrofuran or dioxane, most preferably in tetrahydrofuran, preferably with cooling, especially at a temperature between ⁇ 50° C. and 30° C., more especially at ⁇ 20° C.
  • the quantity of the alkali metal hexaalkyldisilazane used is determined by the amount of nitrile of formula (II) used. At least 1 mol, preferably 1.01 to 1.15 mol of alkali metal hexaalkyldisilazane is used per mol of nitrile of formula (II).
  • the quantity of ethereal solvent used is between 0.7 and 1.5, preferably 0.9 to 1.3 kg per mol of compound of formula (II) used.
  • the resulting suspension is stirred at constant temperature, optionally at a temperature of up to 40° C., preferably at about 20-25° C. over a period of 6 to 24 hours, preferably 8 to 18 hours.
  • the stirring is preferably continued for 10 to 12 hours. During this time the solid which was initially in suspension may go into solution.
  • the mixture can then optionally be diluted either with additional ethereal solvent or with a nonpolar organic solvent, preferably with an aromatic organic solvent.
  • a solvent selected from among toluene, benzene, cyclohexane, methylcyclohexane or xylene is preferably used, of which toluene and xylene are particularly preferred, toluene being most preferred. If the mixture is diluted, it is sufficient to add up to 0.5 L, preferably up to 0.3 L of solvent per mol of compound of formula (II) used.
  • reaction mixture is heated to a reaction temperature of between ⁇ 50° C. and 20° C., more especially ⁇ 20° C. to 10° C., most preferably ⁇ 10 to 0° C. before the addition of the compound of general formula (III). Then the compound of formula (III) is added, in an amount of at least 1 mol, preferably 1.05 to 1.3 mol, more particularly 1.1 to 1.2 mol, per mol of compound (II) used.
  • the product is hydrolysed by the addition of an acid of formula HY, preferably an inorganic or organic acid such as hydrochloric acid, sulphuric acid, phosphoric acid, acetic acid, trifluoroacetic acid, oxalic acid and fumaric acid, particularly aqueous hydrochloric acid.
  • an acid of formula HY preferably an inorganic or organic acid such as hydrochloric acid, sulphuric acid, phosphoric acid, acetic acid, trifluoroacetic acid, oxalic acid and fumaric acid, particularly aqueous hydrochloric acid.
  • an acid of formula HY preferably an inorganic or organic acid such as hydrochloric acid, sulphuric acid, phosphoric acid, acetic acid, trifluoroacetic acid, oxalic acid and fumaric acid, particularly aqueous hydrochloric acid.
  • dilute hydrochloric acid preferably 8-15%, more especially 10-12% strength.
  • the aqueous lower phase is separated off and an organic solvent selected from among acetone, methylisobutylketone, methylethylketone, optionally a mixture of two of the above solvents, most preferably a mixture of acetone and methylisobutylketone in a ratio of 3-1:1, most preferably in a ratio of 2.5-1.5:1, is added to the organic phase.
  • Crystallisation of the compounds of formula (IVA) is initiated by the addition of aqueous hydrochloric acid. About 1 to 1.2 mol of hydrochloric acid is used per mole of the compound of formula (II) originally used.
  • the compounds of formula (IV) are separated from the reaction mixture by conventional methods, e.g. by centrifugation, washed with an organic solvent selected from among acetone, methylisobutylketone, methylethylketone or a carboxylic acid ester, preferably acetone, and dried.
  • An organic solvent selected from among acetone, methylisobutylketone, methylethylketone, tetrahydrofuran or a carboxylic acid ester, preferably acetone, and then a compound of formula (IV) are added to a solution of trisodium citrate dihydrate, sodium hydroxide, potassium hydroxide, alkali or alkaline earth metal salts of organic or inorganic weak acids, preferably trisodium citrate dihydrate, trisodium citrate or sodium hydroxide, most preferably trisodium citrate dihydrate in water at 0-40° C., preferably at 20-25° C., particularly at about 20° C.
  • the compounds of general formula (II) may be obtained by reacting a compound of formula (V) with a compound of formula (VI), as already mentioned. According to the invention, the following procedure may be used.
  • a suitably substituted sulphonic acid chloride optionally the abovementioned organic solvent, an organic base, optionally the abovementioned organic solvent and the aqueous solution of an inorganic base are added one after the other.
  • a suitably substituted sulphonic acid chloride according to the invention might be methanesulphonic acid chloride, para-toluenesulphonic acid chloride, benzenesulphonic acid chloride or trifluoromethanesulphonic acid chloride.
  • methanesulphonic acid chloride is used.
  • the organic bases may be, for example, dimethylaminopyridine, pyridine, methylpyridine, tert. amines, e.g. trimethylamine, triethylamine, diisopropylethylamine, or cyclic amines such as N-methylpyrrolidine or DBU (diazabicycloundecene).
  • Preferred organic amines are N-methylpyrrolidine, trimethylamine, triethylamine or diisopropylethylamine, most preferably triethylamine.
  • the organic base is used in at least a stoichiometric amount, based on the starting compound of formula (V).
  • the organic base is used in an excess of 10-50 mol %, most preferably in about a 30% excess in relation to the compound of formula (V) used.
  • the aqueous solution of an organic base used will usually be an alkali metal or alkaline earth metal hydroxide solution, the alkali metal hydroxide solutions being preferred.
  • the aqueous solutions of potassium hydroxide and sodium hydroxide are particularly important according to the invention. Usually, 20-50% solutions of the abovementioned inorganic hydroxides are used. More concentrated solutions such as, for example, 45% solutions are preferred according to the invention.
  • the inorganic base is used in at least a stoichiometric amount, preferably in an excess of 50-100 mol %.
  • the inorganic base is particularly preferably used in an excess of about 75 mol %, based on the compound of formula (V) added.
  • the reaction mixture may be diluted after the addition of the suitably substituted sulphonic acid chloride or the organic base by the addition of the abovementioned organic solvent. In this case, 2-10%, preferably about 5% of the quantity of solvent put in initially is added.
  • the reaction mixture is diluted with the organic solvent mentioned above.
  • About 0.5 to 1.0 L, preferably between 0.7 and 0.8 L of the solvent used are added, per mol of starting compound of formula (V) used.
  • alkoxides or metal salts of formula (VI) are added.
  • the sodium and potassium phenoxides which may be derived from the compounds of formula (VI) are preferably used.
  • stoichiometric quantities, optionally substoichiometric quantities or an excess of the compound (VI) may be added, based on the educt of formula (V).
  • the reaction is continued for a period of about 1-3 hours, preferably about 1.5 to 2 hours at a temperature of 5-35° C., preferably at about 25° C., and finally stirred for a period of about 1-3 hours, preferably about 1.5-2 hours at a temperature of 50-100° C., preferably at about 70-90° C.
  • the product of formula (II) is crystallised by the addition of a suitable polar solvent selected from among the lower alcohols and water.
  • a solvent mixture consisting of a nonpolar organic solvent, preferably xylene or toluene, most preferably toluene, a polar organic solvent, preferably a lower alcohol such as methanol, ethanol, butanol or isopropanol, especially isopropanol and water.
  • a solvent mixture consisting of a nonpolar organic solvent, preferably xylene or toluene, most preferably toluene, a polar organic solvent, preferably a lower alcohol such as methanol, ethanol, butanol or isopropanol, especially isopropanol and water.
  • the ratio by volume of nonpolar to polar organic solvent to water can vary within the range from 1:7-10:5-8, preferably 1:8-9:6-7.
  • phase transfer catalysts which may be used according to the invention include the quaternary ammonium salts, preferably the halides, sulphates or hydroxides of tetradecyltrimethylammonium, hexadecyltrimethylammonium, tetrabutylammonium, tributylmethylammonium or triethylbenzylammonium.
  • the nonpolar organic solvent may be a chlorinated hydrocarbon such as methylene chloride or preferably, according to the invention, an aromatic hydrocarbon such as benzene, toluene, xylene, preferably toluene.
  • the compounds of formula (V) and (VI) are used in a virtually stoichiometric ratio, and if desired one of the two reactants may also be used in a slight excess (e.g. 15%).
  • the amount of solvent to be used depends on the quantity of educt put in. Between 1 and 2 L of water and between 0.3 and 1.0 L of the organic solvent, preferably between 1.5 and 1.8 L of water and 0.5 to 0.7 L of the organic solvent are used per mol of compound of formula (VI) put in.
  • the reaction is carried out with intensive stirring over a period of 3 to 9, preferably 5 to 7 hours at a temperature of 50 to 100° C., preferably at 70 to 80° C.
  • a polar organic solvent preferably a lower alcohol, most preferably isopropanol is added to the separated organic phase.
  • the crystallisation of the product of formula (II) is completed.
  • the crystallised product of formula (II) is optionally washed with the abovementioned lower alcohol and with water.
  • the compounds of formula (V) wherein X denotes chlorine or bromine may be prepared analogously to methods of synthesis known per se from the compound of formula (V) wherein X denotes hydroxy, using common halogenation reagents such as, for example, thionylchloride, phosphorus oxychloride or phosphorus pentachloride, methanesulphonic acid chloride, benzenesulphochloride, preferably thionylchloride or methanesulphonic acid chloride.
  • common halogenation reagents such as, for example, thionylchloride, phosphorus oxychloride or phosphorus pentachloride, methanesulphonic acid chloride, benzenesulphochloride, preferably thionylchloride or methanesulphonic acid chloride.
  • the compounds of formula (V) wherein X denotes mesylate, triflate or tosylate may be prepared analogously to methods of synthesis known per se from the compound of formula (V) wherein X denotes hydroxy, by reacting with the appropriate sulphonic acid chlorides in aprotic, preferably polar organic solvents, preferably selected from among dichloromethane, N,N-dimethylacetamide, dimethylformamide, acetonitrile, N-methylpyrrolidone, tetraalkylurea in the presence of organic bases, preferably selected from among dimethylaminopyridine, pyridine, methylpyridine, N-methylpyrrolidine, trimethylamine, triethylamine, diisopropylethylamine and DBU (diazabicycloundecene).
  • aprotic preferably polar organic solvents, preferably selected from among dichloromethane, N,N-dimethylacetamide, dimethylformamide, acet
  • the aqueous supernatant is separated off and from this about 100 liters of solvent are distilled off at a sump temperature of 63 to 75° C.
  • the distillation residue is crystallised by the addition of 20 liters of isopropanol at 50 to 60° C. and 150 liters of water at 40 to 50° C. After the suspension has been cooled to 20 to 30° C. the crystals are separated off, washed with 60 to 100 liters of water and batchwise with 25 liters of cold isopropanol and dried in vacuo.
  • the toluene phase purified by extraction is mixed with 11 liters of isopropanol and 80 liters of water and heated to 50 to 55° C. By the addition of 47.4 kg of 45% sodium hydroxide solution and cooling the reaction mixture to 20 to 25° C., a crystal suspension is obtained. The crystals are separated by filtration, washed with about 160 l of toluene and then dried in vacuo.
  • Variant B (Starting From Example 3)
  • Example 4 a sodium-4- ⁇ 1-methyl-1-[4-tetrahydro-pyran-2-yloxy)-phenyl]-ethyl ⁇ -phenoxide, as the tetrahydrate
  • a phase transfer catalyst e.g.: 2.1 kg (2.5 mol) of a 40% aqueous solution of tetradecyltrimethylammonium bromide and 32 liters of toluene and intensively stirred for 6 h at about 80° C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a process suitable for large-scale industrial use for preparing compounds of general formula (I)
Figure US20010009958A1-20010726-C00001
wherein:
R1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono-, di- or trisubstituted by hydroxy; and,
R2 denotes a group selected from among methyl, ethyl, propyl and benzyl.

Description

    RELATED APPLICATIONS
  • Benefit of U.S. Provisional Application Ser. No. 60/177,378, filed on Jan. 24, 2000 is hereby claimed. [0001]
  • FIELD OF THE INVENTION
  • The invention relates to a process for the production of compounds of general formula (I) [0002]
    Figure US20010009958A1-20010726-C00002
  • wherein the groups R[0003] 1 and R2 may have the meanings given in the specification and claims.
  • BACKGROUND OF THE INVENTION
  • From International Patent Application WO 96/02497, benzamidines and aryl-iminomethylcarbamino acid esters are known which are highly effective as pharmaceutical compositions with an LTB[0004] 4-antagonistic activity. Compounds of general formula (I) are of particular importance.
  • The problem of the present invention is to provide a process which can be used for industrial-scale synthesis of compounds of general formula(I) in high yields and with end products of high purity. [0005]
  • DETAILED DESCRIPTION OF THE INVENTION
  • To solve the problem mentioned above, the invention provides a process for preparing compounds of general formula (I) [0006]
    Figure US20010009958A1-20010726-C00003
  • wherein [0007]
  • R[0008] 1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which may be mono-, di- or trisubstituted by hydroxy;
  • R[0009] 2 denotes a group selected from among methyl, ethyl, propyl and benzyl, characterised in that a compound of general formula (II)
    Figure US20010009958A1-20010726-C00004
  • wherein [0010]
  • R[0011] 1′ denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which may be mono-, di- or trisubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and is then treated with a compound of formula (III)
  • R2—O—COX′  (III)
  • wherein [0012]
  • R[0013] 2 is as hereinbefore defined and
  • X′ denotes chlorine, bromine or —O—R[0014] 2, after working up using an acid of formula HY a compound of formula (IV)
  • wherein the groups R[0015] 1 and R2 are as hereinbefore defined and Y denotes any desired acid group,
  • is isolated and from this the compound of formula (I) is liberated. [0016]
  • The compounds of formulae (I) and (IV) also include the corresponding tautomers of formulae (I-T) and (IV-T): [0017]
    Figure US20010009958A1-20010726-C00005
  • The term “alkali metal hexaalkyldisilazane” as used above and hereinafter to denote the reagent which is reacted with the compound of formula (II) generally designates a compound of formula (VIII) [0018]
    Figure US20010009958A1-20010726-C00006
  • wherein [0019]
  • Met denotes an alkali metal, preferably lithium, sodium or potassium, particularly lithium, and [0020]
  • R[0021] 3 independently in each case denotes a C1-4-alkyl group, preferably methyl or ethyl, especially methyl.
  • Most particularly preferred are lithium hexamethyldisilazane, sodium hexamethyldisilazane and potassium hexamethyldisilazane, particularly lithium hexamethyldisilazane. [0022]
  • The term “subsequent reaction” with a compound of formula (III) covers both procedures in which the product of the reaction of the compound of formula (II) with the alkali metal hexamethyldisilazane is reacted with the compound of formula (III) directly, without any further intermediate reaction, and also procedures in which the free amidine base is liberated in the mean time from the product formed. Preferably, the product of the reaction of the compound of formula (II) with the alkali metal hexamethyldisilazane is reacted with the compound of formula (III) directly, especially in a “one-pot synthesis”. [0023]
  • A preferred process for preparing compounds of general formula (I) is one wherein [0024]
  • R[0025] 1 denotes a group selected from among phenyl, benzyl and —C(Me2)phenyl, each of which may be mono- or disubstituted, preferably monosubstituted by hydroxy;
  • R[0026] 2 denotes a group selected from among ethyl, propyl and benzyl, characterised in that a compound of general formula (II)
  • wherein [0027]
  • R[0028] 1′ denotes a group selected from among phenyl, benzyl and —C(Me2)phenyl, each of which may be mono- or disubstituted, preferably monosubstituted by a group —O —PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, preferably 2-tetrahydropyranyloxy,
  • is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and then treated with a compound of formula (III) [0029]
  • R2—O—COX′  (III)
  • wherein [0030]
  • R[0031] 2 is as hereinbefore defined and
  • X′ denotes chlorine, bromine or —O—R[0032] 2,
  • after working up with aqueous hydrochloric acid a compound of formula (IVA) [0033]
    Figure US20010009958A1-20010726-C00007
  • wherein the groups R[0034] 1 and R2 are as hereinbefore defined is isolated and from this the compound of formula (I) is liberated.
  • Particularly preferred is a process for preparing compounds of general formula (I) wherein [0035]
  • R[0036] 1 denotes —C(Me2)phenyl which may optionally be monosubstituted by hydroxy and
  • R[0037] 2 denotes ethyl,
  • characterised in that a compound of general formula (II) [0038]
  • wherein [0039]
  • R[0040] 1′ denotes —C(Me2)phenyl, which may optionally be monosubstituted by a group —O —PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, preferably 2-tetrahydropyranyloxy,
  • is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and then treated with a compound of formula (III) [0041]
  • R2—O—COX′  (III)
  • wherein [0042]
  • R[0043] 2 is as hereinbefore defined and
  • X′ denotes chlorine, bromine or —O—R[0044] 2, preferably chlorine, after working up with aqueous hydrochloric acid a compound of formula (IVA) wherein the groups R1 and R2 are as hereinbefore defined is isolated and from this the compound of formula (I) is liberated.
  • In a particularly preferred embodiment of the process according to the invention, the compound of formula (II) is prepared in a process comprising the following steps: [0045]
  • (a) reacting C[0046] 1-4-alkyl 3-halomethylbenzoates with 4-hydroxybenzonitrile in the manner of a Wilkinson ether synthesis;
  • (b) reductively converting the resulting alkyl 3-(4-cyano-phenoxy)benzoates of formula (VII) [0047]
    Figure US20010009958A1-20010726-C00008
  • wherein R′ denotes C[0048] 1-4-alkyl, into a compound of formula (V)
    Figure US20010009958A1-20010726-C00009
  • wherein X denotes hydroxy; [0049]
  • (c) optionally treating the compound of formula (V) wherein X denotes hydroxy with a halogenating reagent or a sulphonic acid chloride; [0050]
  • (d) reacting the compound of formula (V) wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate or tosylate, with a phenol derivative of formula (VI) [0051]
    Figure US20010009958A1-20010726-C00010
  • wherein R[0052] 1′ denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono-, di- or trisubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy,; optionally in the form of the corresponding sodium or potassium phenoxides, under basic reaction conditions, preferably in a polar organic solvent.
  • The hydrochlorides of formula (IVA) are of central importance in the process according to the invention for preparing the compounds of general formula (I). They are obtained directly in high yields as readily crystallising salts, from which by-products and/or impurities can easily be removed by crystallisation. Accordingly, one aspect of the present invention relates to intermediate products of general formula (IVA) [0053]
    Figure US20010009958A1-20010726-C00011
  • wherein the groups R[0054] 1 and R2 may be as hereinbefore defined.
  • Of the compounds of general formula (IVA) the compound ethyl{[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate hydrochloride is particularly preferred. [0055]
  • The compounds of general formula (II) [0056]
    Figure US20010009958A1-20010726-C00012
  • wherein R[0057] 1′ may be as hereinbefore defined are obtained according to the invention by reacting a compound of formula (V)
    Figure US20010009958A1-20010726-C00013
  • wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate, benzenesulphonate or tosylate, with a compound of formula (VI) [0058]
    Figure US20010009958A1-20010726-C00014
  • wherein R[0059] 1′ may be as hereinbefore defined and wherein the compound of formula (VI) may optionally also be used in the form of the sodium and potassium phenoxides thereof, under basic reaction conditions in a polar organic solvent.
  • It is preferred to prepare compounds of general formula (II) wherein R[0060] 1 may be as hereinbefore defined by reacting a compound of formula (V) wherein X denotes hydroxy, chlorine or mesylate, more preferably hydroxy or chlorine, most preferably chlorine, with a compound of formula (VI) wherein R1′ may be as hereinbefore defined and wherein the compound of formula (VI) is used in the form of the alkali metal phenoxides thereof, preferably in the form of the sodium phenoxides thereof.
  • When the compounds of general formula (I) are synthesised according to the invention, the intermediate products of general formula (V) are of central importance. In another aspect, therefore, the present invention relates to the compounds of general formula (V) [0061]
    Figure US20010009958A1-20010726-C00015
  • as such, wherein X may be as hereinbefore defined and most preferably may denote hydroxy or chlorine. [0062]
  • The compound of formula (VII), one of the starting compounds, is also of particular importance in the synthesis according to the invention of the compounds of general formula (I). Therefore, in another aspect, the present invention relates to the compounds of formula (VII) [0063]
    Figure US20010009958A1-20010726-C00016
  • as such, wherein R′ denotes C[0064] 1-4-alkyl, preferably methyl or ethyl, most preferably methyl.
  • In order to perform the process for preparing the compounds of general formula (I) according to the invention starting from the nitrites of general formula (II) the following method is used: [0065]
  • A compound of general formula (II) is slowly metered into a solution of the alkali metal hexaalkyldisilazane, preferably lithium bis(trimethylsilyl)-amide, sodium bis(trimethylsilyl)-amide, most preferably lithium bis(trimethylsilyl)-amide, in an ethereal or aromatic organic solvent, preferably in a solvent selected from among tetrahydrofaran, toluene, dioxane, more preferably in tetrahydrofuran or dioxane, most preferably in tetrahydrofuran, preferably with cooling, especially at a temperature between −50° C. and 30° C., more especially at −20° C. to 10° C., most especially at about 0° C. The quantity of the alkali metal hexaalkyldisilazane used is determined by the amount of nitrile of formula (II) used. At least 1 mol, preferably 1.01 to 1.15 mol of alkali metal hexaalkyldisilazane is used per mol of nitrile of formula (II). The quantity of ethereal solvent used is between 0.7 and 1.5, preferably 0.9 to 1.3 kg per mol of compound of formula (II) used. [0066]
  • After all the compound of formula (II) has been added the resulting suspension is stirred at constant temperature, optionally at a temperature of up to 40° C., preferably at about 20-25° C. over a period of 6 to 24 hours, preferably 8 to 18 hours. The stirring is preferably continued for 10 to 12 hours. During this time the solid which was initially in suspension may go into solution. [0067]
  • The mixture can then optionally be diluted either with additional ethereal solvent or with a nonpolar organic solvent, preferably with an aromatic organic solvent. A solvent selected from among toluene, benzene, cyclohexane, methylcyclohexane or xylene is preferably used, of which toluene and xylene are particularly preferred, toluene being most preferred. If the mixture is diluted, it is sufficient to add up to 0.5 L, preferably up to 0.3 L of solvent per mol of compound of formula (II) used. [0068]
  • The reaction mixture is heated to a reaction temperature of between −50° C. and 20° C., more especially −20° C. to 10° C., most preferably −10 to 0° C. before the addition of the compound of general formula (III). Then the compound of formula (III) is added, in an amount of at least 1 mol, preferably 1.05 to 1.3 mol, more particularly 1.1 to 1.2 mol, per mol of compound (II) used. [0069]
  • After the reaction is complete, the product is hydrolysed by the addition of an acid of formula HY, preferably an inorganic or organic acid such as hydrochloric acid, sulphuric acid, phosphoric acid, acetic acid, trifluoroacetic acid, oxalic acid and fumaric acid, particularly aqueous hydrochloric acid. About 1 mol of acid, particularly hydrochloric acid, is used per mol of the compound of formula (II) originally used. According to the invention, it is preferable to add dilute hydrochloric acid (preferably 8-15%, more especially 10-12% strength). [0070]
  • After a period of about 10 minutes to 1 hour the aqueous lower phase is separated off and an organic solvent selected from among acetone, methylisobutylketone, methylethylketone, optionally a mixture of two of the above solvents, most preferably a mixture of acetone and methylisobutylketone in a ratio of 3-1:1, most preferably in a ratio of 2.5-1.5:1, is added to the organic phase. Crystallisation of the compounds of formula (IVA) is initiated by the addition of aqueous hydrochloric acid. About 1 to 1.2 mol of hydrochloric acid is used per mole of the compound of formula (II) originally used. It is preferred according to the invention to add preferably 32-37%, most preferably 37% hydrochloric acid. The compounds of formula (IV) are separated from the reaction mixture by conventional methods, e.g. by centrifugation, washed with an organic solvent selected from among acetone, methylisobutylketone, methylethylketone or a carboxylic acid ester, preferably acetone, and dried. [0071]
  • The release of the compounds of formula (I) from the acid addition salts of formula (IV), particularly from the hydrochlorides of formula (IVA), is generally carried out with basic reactants under reaction conditions which are as neutral as possible, preferably in the presence of buffer systems, according to the method described hereinafter: [0072]
  • An organic solvent selected from among acetone, methylisobutylketone, methylethylketone, tetrahydrofuran or a carboxylic acid ester, preferably acetone, and then a compound of formula (IV) are added to a solution of trisodium citrate dihydrate, sodium hydroxide, potassium hydroxide, alkali or alkaline earth metal salts of organic or inorganic weak acids, preferably trisodium citrate dihydrate, trisodium citrate or sodium hydroxide, most preferably trisodium citrate dihydrate in water at 0-40° C., preferably at 20-25° C., particularly at about 20° C. About 1-2 mol, preferably about 1.5 mol of the sodium or potassium citrate used and about 1 to 3 L of the abovementioned organic solvent, preferably about 2 L, are used per mol of compound of formula (IV) put in. The mixture is stirred at constant temperature over a period of 20 minutes to 2 hours, preferably 1-1.2 hours. [0073]
  • When strong bases such as sodium hydroxide are used, the method of addition may be reversed if desired. The crystalline product is separated off by filtration, for example, washed with water to remove any salt, and with the abovementioned organic solvent and finally dried. [0074]
  • The compounds of general formula (II) may be obtained by reacting a compound of formula (V) with a compound of formula (VI), as already mentioned. According to the invention, the following procedure may be used. [0075]
  • The compound of formula (V) wherein X denotes hydroxy is dissolved in an organic solvent, if possible an aprotic-polar organic solvent, preferably N,N-dimethylacetamide, acetone, methylethylketone, methylisobutylketone, N-methylpyrrolidone, N,N-dimethylformamide, tetraalkylurea, most preferably in N,N-dimethylacetamide. 0.5 to 1.0, preferably about 0.7 L of solvent are used at this point per mol of starting compound according to the invention. Then the solution thus obtained is cooled to a temperature of <10° C., preferably to a temperature between +5° C. and −20° C., most preferably to about −10° C. to 0° C. Then a suitably substituted sulphonic acid chloride, optionally the abovementioned organic solvent, an organic base, optionally the abovementioned organic solvent and the aqueous solution of an inorganic base are added one after the other. A suitably substituted sulphonic acid chloride according to the invention might be methanesulphonic acid chloride, para-toluenesulphonic acid chloride, benzenesulphonic acid chloride or trifluoromethanesulphonic acid chloride. Preferably, methanesulphonic acid chloride is used. The organic bases may be, for example, dimethylaminopyridine, pyridine, methylpyridine, tert. amines, e.g. trimethylamine, triethylamine, diisopropylethylamine, or cyclic amines such as N-methylpyrrolidine or DBU (diazabicycloundecene). Preferred organic amines are N-methylpyrrolidine, trimethylamine, triethylamine or diisopropylethylamine, most preferably triethylamine. The organic base is used in at least a stoichiometric amount, based on the starting compound of formula (V). Preferably, the organic base is used in an excess of 10-50 mol %, most preferably in about a 30% excess in relation to the compound of formula (V) used. The aqueous solution of an organic base used will usually be an alkali metal or alkaline earth metal hydroxide solution, the alkali metal hydroxide solutions being preferred. The aqueous solutions of potassium hydroxide and sodium hydroxide are particularly important according to the invention. Usually, 20-50% solutions of the abovementioned inorganic hydroxides are used. More concentrated solutions such as, for example, 45% solutions are preferred according to the invention. Based on the compound of formula (V) used, the inorganic base is used in at least a stoichiometric amount, preferably in an excess of 50-100 mol %. The inorganic base is particularly preferably used in an excess of about 75 mol %, based on the compound of formula (V) added. If desired, the reaction mixture may be diluted after the addition of the suitably substituted sulphonic acid chloride or the organic base by the addition of the abovementioned organic solvent. In this case, 2-10%, preferably about 5% of the quantity of solvent put in initially is added. [0076]
  • In any case, after all the aqueous solution of the inorganic base has been added, the reaction mixture is diluted with the organic solvent mentioned above. About 0.5 to 1.0 L, preferably between 0.7 and 0.8 L of the solvent used are added, per mol of starting compound of formula (V) used. Then alkoxides or metal salts of formula (VI) are added. The sodium and potassium phenoxides which may be derived from the compounds of formula (VI) are preferably used. According to the invention, stoichiometric quantities, optionally substoichiometric quantities or an excess of the compound (VI) may be added, based on the educt of formula (V). After all the compound (VI) has been added, the reaction is continued for a period of about 1-3 hours, preferably about 1.5 to 2 hours at a temperature of 5-35° C., preferably at about 25° C., and finally stirred for a period of about 1-3 hours, preferably about 1.5-2 hours at a temperature of 50-100° C., preferably at about 70-90° C. After the reaction has ended the product of formula (II) is crystallised by the addition of a suitable polar solvent selected from among the lower alcohols and water. [0077]
  • In order to obtain high yields of particularly pure products, it has proved preferable according to the invention to add, for the crystallisation, a solvent mixture consisting of a nonpolar organic solvent, preferably xylene or toluene, most preferably toluene, a polar organic solvent, preferably a lower alcohol such as methanol, ethanol, butanol or isopropanol, especially isopropanol and water. The ratio by volume of nonpolar to polar organic solvent to water can vary within the range from 1:7-10:5-8, preferably 1:8-9:6-7. By cooling to below 50° C., preferably to about 30° C., the crystallisation of the product of formula (II) is completed. After isolation, the crystallised product is optionally washed with the abovementioned lower alcohol and with water. [0078]
  • If the compounds of formula (II) are to be obtained from the compounds of formula (V) wherein X has a meaning other than hydroxy, the following procedure may be used according to the invention. [0079]
  • The sodium or potassium phenoxide derived from the compounds of formula (VI) is taken up in water together with a compound of formula (V), mixed with a nonpolar organic solvent and optionally reacted under phase transfer conditions. The phase transfer catalysts which may be used according to the invention include the quaternary ammonium salts, preferably the halides, sulphates or hydroxides of tetradecyltrimethylammonium, hexadecyltrimethylammonium, tetrabutylammonium, tributylmethylammonium or triethylbenzylammonium. The nonpolar organic solvent may be a chlorinated hydrocarbon such as methylene chloride or preferably, according to the invention, an aromatic hydrocarbon such as benzene, toluene, xylene, preferably toluene. The compounds of formula (V) and (VI) are used in a virtually stoichiometric ratio, and if desired one of the two reactants may also be used in a slight excess (e.g. 15%). The amount of solvent to be used depends on the quantity of educt put in. Between 1 and 2 L of water and between 0.3 and 1.0 L of the organic solvent, preferably between 1.5 and 1.8 L of water and 0.5 to 0.7 L of the organic solvent are used per mol of compound of formula (VI) put in. The reaction is carried out with intensive stirring over a period of 3 to 9, preferably 5 to 7 hours at a temperature of 50 to 100° C., preferably at 70 to 80° C. Then, to crystallise the product, a polar organic solvent, preferably a lower alcohol, most preferably isopropanol is added to the separated organic phase. By cooling to below 50° C., preferably to about 30° C., the crystallisation of the product of formula (II) is completed. After being isolated, the crystallised product of formula (II) is optionally washed with the abovementioned lower alcohol and with water. [0080]
  • The starting compounds of formula (V) [0081]
    Figure US20010009958A1-20010726-C00017
  • which, as already mentioned, relate to one aspect of the present invention, may be prepared analogously to methods of synthesis known per se. The compound of formula (V) wherein X denotes hydroxy may be prepared by reacting methyl 3-halomethyl-benzoates with 4-hydroxybenzonitrile, for example, in a Wilkinson ether synthesis. The methyl 3-(4-cyano-phenoxy)-benzoate (VII) thus obtained can be reductively converted into the compound of general formula (V) wherein X=hydroxy (=4-(3-hydroxymethyl-benzyloxy)-benzonitrile) by the analogous use of current standard procedures. [0082]
  • The compounds of formula (V) wherein X denotes chlorine or bromine may be prepared analogously to methods of synthesis known per se from the compound of formula (V) wherein X denotes hydroxy, using common halogenation reagents such as, for example, thionylchloride, phosphorus oxychloride or phosphorus pentachloride, methanesulphonic acid chloride, benzenesulphochloride, preferably thionylchloride or methanesulphonic acid chloride. [0083]
  • The compounds of formula (V) wherein X denotes mesylate, triflate or tosylate may be prepared analogously to methods of synthesis known per se from the compound of formula (V) wherein X denotes hydroxy, by reacting with the appropriate sulphonic acid chlorides in aprotic, preferably polar organic solvents, preferably selected from among dichloromethane, N,N-dimethylacetamide, dimethylformamide, acetonitrile, N-methylpyrrolidone, tetraalkylurea in the presence of organic bases, preferably selected from among dimethylaminopyridine, pyridine, methylpyridine, N-methylpyrrolidine, trimethylamine, triethylamine, diisopropylethylamine and DBU (diazabicycloundecene). [0084]
  • The following Examples serve to illustrate methods of synthesis according to the invention, carried out by way of example, for preparing the compound of formula (I). They must be considered as possible methods given by way of example, without restricting the invention to their content. [0085]
  • EXAMPLE 1 Methyl 3-(4-cyano-phenoxymethyl)-benzoate:
  • 10.00 kg (43.6 mol) of methyl 3-(bromomethyl)benzoate and 5.21 kg (43.74 mol) of 4-hydroxybenzonitrile are dissolved in 100 liters of acetone and stirred with 8.4 kg (60.7 mol) of potassium carbonate in the presence of 0.1 kg of sodium iodide for about 4 h under reflux conditions. Then 35 liters of acetone are distilled off and 100 liters of water are added at reflux conditions. The reaction mixture is cooled to 20° C. and the crystallisation is completed by the addition of another 30 liters of water. The crystals formed are separated off, washed with 50 liters of water and dried in vacuo. [0086]
  • Yield: 11.1 kg (95%) of methyl 3-(4-cyano-phenoxymethyl)-benzoate; [0087]
  • Melting point 109 . . . 112° C., white solid, [0088]
  • TLC (silica gel 60 F254-ready-made plate (Merck): Rf=0.5 (toluene:acetone=9:1) [0089]
  • EXAMPLE 2: 4-(3-hydroxymethyl-benzyloxy)-benzonitrile:
  • 20.05 kg (26.7 mol) of methyl 3-(4-cyano-phenoxymethyl)-benzoate are dissolved in 100 liters of THF and 40 liters of methanol. At 40 to 45° C., 8.51 kg of sodium boranate are added in batches. The reaction is completed by stirring the reaction mixture at 61 to 63° C. for about 5 hours. The reaction mixture is then cooled to 25° C. and 90 liters of a 15% sodium hydroxide solution are added. After stirring, the aqueous supernatant is separated off and mixed with 30 liters of a 22.5% sodium hydroxide solution. After stirring, the aqueous supernatant is separated off and from this about 100 liters of solvent are distilled off at a sump temperature of 63 to 75° C. The distillation residue is crystallised by the addition of 20 liters of isopropanol at 50 to 60° C. and 150 liters of water at 40 to 50° C. After the suspension has been cooled to 20 to 30° C. the crystals are separated off, washed with 60 to 100 liters of water and batchwise with 25 liters of cold isopropanol and dried in vacuo. [0090]
  • Yield: 15.8 kg (88%) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile; [0091]
  • Melting point (DSC): 110-115° C., white solid [0092]
  • IR: 3444/cm (OH band); 2229/cm (CN band) [0093]
  • EXAMPLE 3: 4-(3-Chloromethyl-benzyloxy)-benzonitrile:
  • Variant A: [0094]
  • 7.18 g (30 mmol) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile are dissolved in 80 ml of dichloromethane, mixed with 4.13 g (35 mmol) of thionylchloride and 0.1 g of DMF and stirred while heating to 40° C. until the development of gas has ceased. After cooling, the organic reaction mixture is washed successively with water and dilute sodium hydroxide solution and crystallised by evaporation. [0095]
  • Yield: 6.8 g (88%) of 4-(3-chloromethyl-benzyloxy)-benzonitrile; [0096]
  • TLC (silica gel 60 F254-ready-made plate (Merck): Rf=0.9 (toluene-acetone=9:1), Rf=0.44 (toluene) [0097]
  • Variant B: [0098]
  • 7.18 g (30 mmol) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile are dissolved in 22 ml of N,N-dimethylacetamide, mixed with 4.47 g (39 mmol) of methanesulphonic acid chloride and 3.95 g (39 mmol) of triethylamine and stirred for 10 hours at 20-30° C. Then the triethylammonium chloride precipitated is filtered off, the filtrate is mixed with 30 ml of isopropanol and the desired 4-(3-chloromethyl-benzyloxy)-benzonitrile is crystallised by the metered addition of 30 ml of water. The suspension is stirred for 15 min at 10° C. and filtered. The crystals are washed with a mixture of 5 ml of isopropanol and 20 ml water and dried at 20° C. in vacuo. Yield: 6.8 g (88%) of 4-(3-chloromethyl-benzyloxy)-benzonitrile Melting point: 65-68° C. [0099]
  • EXAMPLE 4 Sodium-4-{1-methyl-1-[4-tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-phenoxide
  • 121.8 kg of bisphenol A are suspended in 480 l of toluene and 46 l of THF. After the addition of the catalyst (1.3 kg of 37% hydrochloric acid), 44.9 kg of 3,4-dihydro-2H-pyran are metered in so as not to exceed a temperature of 40° C. The solid then goes into solution. Then the reaction mixture is mixed with 26. 4 kg of 45% sodium hydroxide solution and 260 l of water. The organic upper phase is separated off and about 50 l of solvent are eliminated by distillation. At 30 to 40° C. the organic phase is washed several times with dilute sodium hydroxide solution so that sufficient purity can be achieved (monitored by TLC). If the aqueous lower phase is in the pH range 11.8 to 12.2, excess bisphenol A can easily be separated off. [0100]
  • The toluene phase purified by extraction is mixed with 11 liters of isopropanol and 80 liters of water and heated to 50 to 55° C. By the addition of 47.4 kg of 45% sodium hydroxide solution and cooling the reaction mixture to 20 to 25° C., a crystal suspension is obtained. The crystals are separated by filtration, washed with about 160 l of toluene and then dried in vacuo. [0101]
  • Yield: 96.5 kg (54%) (as the tetra-hydrate) [0102]
  • EXAMPLE 5 Synthesis of 4-[3-(4-{1-methyl-1-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-phenoxymethyl)-benzyloxy]-benzonitrile:
  • Variant A: (Starting From Example 2) [0103]
  • 28 kg (244 mol) of methanesulphonic acid chloride, 6 liters of N,N-dimethylacetamide, 24.7 kg (244 mol) of triethylamine, 6 liters of N,N-dimethylacetamide, 29.4 kg of 45% sodium hydroxide solution, 143 liters of N,N-dimethylacetamide, 59.7 kg (178.5 mol) of Example 4 (≡sodium-4-{1-methyl-1-[4-tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-phenoxide, as the tetrahydrate) are metered successively into a solution of 45 kg (188 mol) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile (Example 2) in 133 liters of N,N-dimethylacetamide at about −10° to 0° C. Then the reaction mixture is stirred for 2 h at 25° C. and for another 1.5 h at 75 to 80° C. After the addition of 32 liters of toluene, 255 liters of isopropanol and 200 liters of water crystallisation begins which is completed by cooling to 30° C. The crystalline product is separated off by filtration, washed with isopropanol and water and then dried in vacuo. Yield: 85 kg (90%) of 4-[3-(4-{1-methyl-1-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-ethyl }-phenoxymethyl)-benzyloxy]-benzonitrile; [0104]
  • Variant B: (Starting From Example 3) [0105]
  • 19.4 kg (50 mol) of Example 4 (a sodium-4-{1-methyl-1-[4-tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-phenoxide, as the tetrahydrate) and 12.2 kg (47.5 mol) of Example 3 (=-4-(3-chloromethyl-benzyloxy)-benzonitrile) are mixed with 85 liters of water, a phase transfer catalyst (e.g.: 2.1 kg (2.5 mol) of a 40% aqueous solution of tetradecyltrimethylammonium bromide and 32 liters of toluene and intensively stirred for 6 h at about 80° C. Then 44 liters of isopropanol are metered into the separated organic upper phase, at 50 to 70° C., the crystal suspension obtained is cooled to about 25° C. and filtered. The crystals separated off are washed twice with 25 liters of cold isopropanol and dried in vacuo. [0106]
  • Yield: 22.8 kg (90%) of 4-[3-(4-{1-methyl-1-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-ethyl }-phenoxymethyl)-benzyloxy]-benzonitrile; [0107]
  • EXAMPLE 6 Ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate hydrochloride
  • 132 kg (247 mol) of 4-(3-{4-[1-(4-tetrahydropyranyl-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-benzonitrile (Example 5)are metered into a solution of 45.5 kg (272 mol) of lithium-bis(trimethylsilyl-)amide in 266 kg of THF at about 0° C. The resulting suspension is stirred for about 10 h at about 25° C. The solid then goes into solution. After the addition of 68 liters of toluene the reaction mixture is cooled to −10° to 0° C. and at this temperature 30.8 kg (284 mol) of ethyl chloroformate are added to the reaction vessel. Once the reaction has finished completely 24.3 kg of 37% hydrochloric acid (diluted with 50 liters of water) are metered in and about 20 min later the aqueous lower phase is separated off. Crystallisation of the intended product is initiated by the subsequent addition of 106 liters of acetone, 48 liters of methylisobutylketone and 24.3 kg of 37% hydrochloric acid. [0108]
  • 123 kg (87%) of ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy) phenyl]-imino-methyl}-carbaminate hydrochloride are obtained after centrifuging, washing with acetone and drying in vacuo. [0109]
  • Melting point: 170-175° C. [0110]
  • EXAMPLE 7 Ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate:
  • 466 liters of acetone and 142 kg of ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate hydrochloride (Example 6) are added to a solution of 109 kg of trisodium citrate dihydrate at 20° C. After one hour's stirring the crystalline product is separated off by filtration, washed with water to remove any salts, washed again with about 100 liters of acetone and finally dried in vacuo. [0111]
  • 116 kg (90%) of ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate are obtained. [0112]

Claims (8)

What is claimed is:
1. A process for preparing a compound of the formula (I)
Figure US20010009958A1-20010726-C00018
wherein
R1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono-, di- or trisubstituted by hydroxy;
R2 denotes a group selected from among methyl, ethyl, propyl and benzyl, which process comprises the following steps:
(a) reacting a compound of the formula (II)
Figure US20010009958A1-20010726-C00019
wherein
R1′ denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono-, di- or trisubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy,
with an alkali metal hexaalkyldisilazane of the formula (VIII)
Figure US20010009958A1-20010726-C00020
wherein
Met denotes an alkali metal, and
R3 independently in each case denotes a C1-4-alkyl group;
(b) treating the product of step (a) with a compound of the formula (III)
R2—O—COX′  (III)
wherein:
R2 is as hereinbefore defined in this claim and
X′ denotes chlorine, bromine or —O—R2, wherein R2 is as hereinbefore defined in this claim;
(c) treating the product of step (b) with a protic acid of formula HY, wherein Y denotes the counter ion, to yield a compound of the formula (IV)
Figure US20010009958A1-20010726-C00021
or a tautomer thereof, wherein the groups R1, R2 and Y are as hereinbefore defined in this claim;
(d) isolating the compound of the formula IV produced in step (c);
(e) treating the isolated compound of the formula IV, produced in step (d) with a base to produce the compound of the formula I.
2. The process according to
claim 1
, wherein:
(a) in the compound of formula I,
R1 denotes a group selected from among phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono- or disubstituted by hydroxy;
R2 denotes a group selected from among ethyl, propyl and benzyl;
(b) in the compound of formula II,
R1′ denotes a group selected from among phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono- or disubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy;
(c) in the compound of formula III,
R2 is as hereinbefore defined in this claim, and
X′ denotes a chlorine or bromine atom or the group —OR2, wherein R2 is as hereinbefore defined in this claim; and,
(d) the acid HY is hydrochloric acid and the intermediate produced in step (c) is a compound of the formula IVA
Figure US20010009958A1-20010726-C00022
or a tautomer thereof, wherein the groups R1, R2 and Y are as hereinbefore defined in this claim.
3. The process according to
claim 1
, wherein:
(a) in the compound of formula I,
R1 denotes —C(Me2)phenyl, which is optionally monosubstituted by hydroxy;
R2 denotes ethyl;
(b) in the compound of formula II,
R1′ denotes —C(Me2)phenyl, which is optionally monosubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy; and,
(c) in the compound of formula III,
R2 is as hereinbefore defined in this claim, and
X′ denotes a chlorine or bromine atom or the group —OR2, wherein R2 is as hereinbefore defined in this claim.
4. A process for preparing a compound of formula II
Figure US20010009958A1-20010726-C00023
which process comprises the following steps:
(a) reacting a C1-4-alkyl 3-halomethylbenzoate of the formula
Figure US20010009958A1-20010726-C00024
wherein R′ denotes a C1-4-alkyl group and Hal denotes a halogen atom, with 4-hydroxybenzonitrile
Figure US20010009958A1-20010726-C00025
in the manner of a Wilkinson ether synthesis;
(b) reductively converting the resulting alkyl 3-(4-cyano-phenoxy)benzoate of the formula VII
Figure US20010009958A1-20010726-C00026
wherein R′ is as hereinbefore defined in this claim, into a compound of the formula (V)
Figure US20010009958A1-20010726-C00027
wherein X denotes hydroxy;
(c) optionally treating the compound of formula (V) wherein X denotes hydroxy with a chlorinating or brominating reagent or a sulphonic acid chloride (selected from methane sulfonic acid chloride, trifluoromethane sulfonic acid chloride and paratoluene sulfonic acid chloride), to yield a compound of the formula V wherein X denotes chlorine, bromine, mesylate, triflate or tosylate; and,
(d) reacting the compound of formula (V) wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate or tosylate, with a phenol derivative of formula (VI)
Figure US20010009958A1-20010726-C00028
wherein R1′ denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono-, di- or trisubstituted by a group —O—PG, the group —O—PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy, 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy; and wherein said phenol derivative of the formula VI is optionally in the form of the corresponding sodium or potassium phenoxide, under basic reaction conditions, in a polar organic solvent, to yield a compound of the formula II.
5. A compound of the formula (IVA) or the tautomeric form thereof
Figure US20010009958A1-20010726-C00029
wherein the groups R1 and R2 are defined as in
claim 1
,
2
or 3.
6. A compound of the formula formula (V),
Figure US20010009958A1-20010726-C00030
wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate or tosylate.
7. A compound according to
claim 6
, wherein X denotes hydroxy or chlorine.
8. A compound of the formula (VII)
Figure US20010009958A1-20010726-C00031
wherein R′ denotes C1-4-alkyl.
US09/757,253 2000-01-12 2001-01-09 Process for preparing aryl-iminomethyl-carbamino acid esters Expired - Lifetime US6417382B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/757,253 US6417382B2 (en) 2000-01-12 2001-01-09 Process for preparing aryl-iminomethyl-carbamino acid esters
US10/138,955 US6861547B2 (en) 2000-01-12 2002-05-05 Process for preparing aryl-iminomethyl-carbamino acid esters

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10000907 2000-01-12
DEDE10000907.7 2000-01-12
DE10000907A DE10000907A1 (en) 2000-01-12 2000-01-12 Process for the preparation of aryl-iminomethyl-carbamic acid esters
US17737800P 2000-01-24 2000-01-24
US09/757,253 US6417382B2 (en) 2000-01-12 2001-01-09 Process for preparing aryl-iminomethyl-carbamino acid esters

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/138,955 Continuation US6861547B2 (en) 2000-01-12 2002-05-05 Process for preparing aryl-iminomethyl-carbamino acid esters

Publications (2)

Publication Number Publication Date
US20010009958A1 true US20010009958A1 (en) 2001-07-26
US6417382B2 US6417382B2 (en) 2002-07-09

Family

ID=27213563

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/757,253 Expired - Lifetime US6417382B2 (en) 2000-01-12 2001-01-09 Process for preparing aryl-iminomethyl-carbamino acid esters
US10/138,955 Expired - Lifetime US6861547B2 (en) 2000-01-12 2002-05-05 Process for preparing aryl-iminomethyl-carbamino acid esters

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/138,955 Expired - Lifetime US6861547B2 (en) 2000-01-12 2002-05-05 Process for preparing aryl-iminomethyl-carbamino acid esters

Country Status (1)

Country Link
US (2) US6417382B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055065A2 (en) * 2001-01-16 2002-07-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
AU2005266088A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a COX-2 selective inhibitor and a LTB4 receptor antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
US5246965A (en) 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
DE4424713A1 (en) 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituted benzamidines, their preparation and their use as pharmaceutical substances

Also Published As

Publication number Publication date
US6861547B2 (en) 2005-03-01
US20020137963A1 (en) 2002-09-26
US6417382B2 (en) 2002-07-09

Similar Documents

Publication Publication Date Title
US7312345B2 (en) Process for the preparation of dronedarone
US7417149B2 (en) Process for the preparation of Montelukast
US6680386B2 (en) Process for preparing 2-(4-chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic acid
US6417382B2 (en) Process for preparing aryl-iminomethyl-carbamino acid esters
US20120065397A1 (en) Preparation of ketone amides
CA2399598C (en) Process for preparing aryl-iminomethyl-carbamino acid esters
US9533956B2 (en) Method of manufacturing pyridazinone compound
US5739402A (en) Process for the preparation of mixtures of isomers of O-phenoxy-alkylhydroxylamines or O-phenoxyalkyloximes
US6900326B2 (en) Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound
US7329780B2 (en) Method of preparing optically pure phenethylamine derivatives
KR910004177B1 (en) Anilinopyrimidine derivatives
US6548678B1 (en) Method for producing 5-phenoxycarbonylbenzotriazole
JPH09124610A (en) 1,2-diformylhexahydropyridazine, its production and production of hexahydropyridazine
JP2569732B2 (en) Ester derivative and method for producing the same
JPH0753456A (en) 1-fluoro-2-oxocycloalkanecarboxylic acid derivative and its salt
KR20050103610A (en) Process for preparing hydrochloride propiverin
JPH02233646A (en) Production of 5-fluoro-2-nitrophenoxy acetate
JPH11140062A (en) Production of 2-substituted 5-formylthiazole
JPH0330594B2 (en)
JPH11228541A (en) Production of 2-alkoxy-6-amino-3-pyridinecarboxylic acid compound

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOEHRINGER INGELHEIM PHARMA KG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRANDENBURG, JOERG;SCHMID, ROLF;SOYKA, RAINER;AND OTHERS;REEL/FRAME:011621/0155;SIGNING DATES FROM 20010130 TO 20010202

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, GERMANY

Free format text: CHANGE OF NAME;ASSIGNOR:BOEHRINGER INGELHEIM PHARMA KG;REEL/FRAME:014083/0173

Effective date: 20030218

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12